NeuroOne Medical Technologies Corporation
NMTC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $35,680 | $32,969 | $26,451 | $25,469 |
| - Cash | $6,570 | $8,040 | $1,320 | $1,134 |
| + Debt | $143 | $296 | $311 | $342 |
| Enterprise Value | $29,253 | $25,225 | $25,442 | $24,676 |
| Revenue | $2,741 | $1,696 | $1,387 | $3,274 |
| % Growth | 61.6% | 22.3% | -57.7% | – |
| Gross Profit | $1,529 | $915 | $771 | $1,927 |
| % Margin | 55.8% | 53.9% | 55.6% | 58.9% |
| EBITDA | -$1,555 | -$1,425 | -$2,205 | $2,175 |
| % Margin | -56.7% | -84% | -159% | 66.4% |
| Net Income | -$1,619 | -$1,501 | -$2,271 | $1,785 |
| % Margin | -59.1% | -88.5% | -163.8% | 54.5% |
| EPS Diluted | -0.044 | -0.031 | -0.073 | 0.058 |
| % Growth | -42.1% | 57.7% | -226.3% | – |
| Operating Cash Flow | -$1,526 | -$1,464 | -$56 | $208 |
| Capital Expenditures | -$11 | -$44 | -$3 | -$24 |
| Free Cash Flow | -$1,536 | -$1,507 | -$59 | $184 |